Everything Investors Need to Know About Investigational New Drug SubmissionsThe Motley Fool • 10/03/20
Canada Begins Reviewing AstraZeneca's Coronavirus Vaccine, U.S. Study Still Not RestartedThe Motley Fool • 10/02/20
European Regulators Begin Accelerated Review of AstraZeneca's COVID-19 Vaccine Candidate, but FDA Widens Its Investigation Into Clinical Trial IllnessThe Motley Fool • 10/01/20
AstraZeneca's COVID-19 Vaccine Trial Delays May Worsen As FDA Widens InvestigationBenzinga • 10/01/20
4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?24/7 Wall Street • 09/30/20
LogicBio Therapeutics to Present at the Jefferies Virtual Gene Editing/Therapy Summit October 2, 2020GlobeNewsWire • 09/25/20
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020GlobeNewsWire • 09/25/20
AstraZeneca Signs Deal With Canada to Provide 20 Million Coronavirus Vaccine DosesThe Motley Fool • 09/25/20
AstraZeneca coronavirus vaccine trials remains on hold in the U.S., HHS chief Azar saysCNBC • 09/23/20
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supplyPRNewsWire • 09/21/20